T8	Subject 24 104	two female patients diagnosed with relapsing-remitting multiple sclerosis (RRMS)
T9	Effect 119 162	inflammatory musculoskeletal manifestations
T11	Treatment 174 182	IFN-beta
T13	Population 24 27	two
T14	Gender 28 34	female
T15	Drug 174 182	IFN-beta
T16	Treat-Disorder 59 97	relapsing-remitting multiple sclerosis
T10	Adverse_event 109 118	developed
E1	Adverse_event:T10